Genomic analyses of musashi1 downstream targets show a strong association with cancer-related processes.

PubWeight™: 1.29‹?› | Rank: Top 10%

🔗 View Article (PMC 2673281)

Published in J Biol Chem on March 03, 2009

Authors

Raquel de Sousa Abreu1, Patricia C Sanchez-Diaz, Christine Vogel, Suzanne C Burns, Daijin Ko, Tarea L Burton, Dat T Vo, Soudhamini Chennasamudaram, Shu-Yun Le, Bruce A Shapiro, Luiz O F Penalva

Author Affiliations

1: Children's Cancer Research Institute, University of Texas Health Science Center at San Antonio, Department of Cellular and Structural Biology, San Antonio, TX 78229-390, USA.

Articles citing this

Musashi1 regulates breast tumor cell proliferation and is a prognostic indicator of poor survival. Mol Cancer (2010) 1.31

Musashi-2 controls cell fate, lineage bias, and TGF-β signaling in HSCs. J Exp Med (2014) 1.25

RNA-binding protein Musashi1 modulates glioma cell growth through the post-transcriptional regulation of Notch and PI3 kinase/Akt signaling pathways. PLoS One (2012) 1.14

The oncogenic RNA-binding protein Musashi1 is regulated by HuR via mRNA translation and stability in glioblastoma cells. Mol Cancer Res (2012) 1.02

RNA-binding protein PCBP2 modulates glioma growth by regulating FHL3. J Clin Invest (2013) 1.01

The SOX2-interactome in brain cancer cells identifies the requirement of MSI2 and USP9X for the growth of brain tumor cells. PLoS One (2013) 0.99

Context-dependent regulation of Musashi-mediated mRNA translation and cell cycle regulation. Cell Cycle (2011) 0.98

The RNA-binding protein Musashi1 affects medulloblastoma growth via a network of cancer-related genes and is an indicator of poor prognosis. Am J Pathol (2012) 0.98

Tetraspanin 3 Is Required for the Development and Propagation of Acute Myelogenous Leukemia. Cell Stem Cell (2015) 0.96

The RNA-binding protein Musashi-1 regulates proteasome subunit expression in breast cancer- and glioma-initiating cells. Stem Cells (2014) 0.95

Structure of Musashi1 in a complex with target RNA: the role of aromatic stacking interactions. Nucleic Acids Res (2011) 0.95

Visual activity regulates neural progenitor cells in developing xenopus CNS through musashi1. Neuron (2010) 0.93

A comprehensive in silico expression analysis of RNA binding proteins in normal and tumor tissue: Identification of potential players in tumor formation. RNA Biol (2009) 0.91

Musashi-1 post-transcriptionally enhances phosphotyrosine-binding domain-containing m-Numb protein expression in regenerating gastric mucosa. PLoS One (2013) 0.90

A conserved three-nucleotide core motif defines Musashi RNA binding specificity. J Biol Chem (2014) 0.88

Musashi1 as a potential therapeutic target and diagnostic marker for lung cancer. Oncotarget (2013) 0.87

Genomic analyses reveal broad impact of miR-137 on genes associated with malignant transformation and neuronal differentiation in glioblastoma cells. PLoS One (2014) 0.86

Msi1 promotes tumor growth and cell proliferation by targeting cell cycle checkpoint proteins p21, p27 and p53 in cervical carcinomas. Oncotarget (2014) 0.86

The Msi Family of RNA-Binding Proteins Function Redundantly as Intestinal Oncoproteins. Cell Rep (2015) 0.84

Defining potentially conserved RNA regulons of homologous zinc-finger RNA-binding proteins. Genome Biol (2011) 0.84

Allosteric inhibition of a stem cell RNA-binding protein by an intermediary metabolite. Elife (2014) 0.83

Autoregulation of Musashi1 mRNA translation during Xenopus oocyte maturation. Mol Reprod Dev (2012) 0.82

A 1536-well fluorescence polarization assay to screen for modulators of the MUSASHI family of RNA-binding proteins. Comb Chem High Throughput Screen (2014) 0.81

RNA-Binding Protein Musashi1 Is a Central Regulator of Adhesion Pathways in Glioblastoma. Mol Cell Biol (2015) 0.79

Alternative polyadenylation in glioblastoma multiforme and changes in predicted RNA binding protein profiles. OMICS (2013) 0.78

RNA-binding Protein Musashi Homologue 1 Regulates Kidney Fibrosis by Translational Inhibition of p21 and Numb mRNA. J Biol Chem (2016) 0.78

Musashi RNA-Binding Proteins as Cancer Drivers and Novel Therapeutic Targets. Clin Cancer Res (2017) 0.78

Musashi1 Impacts Radio-Resistance in Glioblastoma by Controlling DNA-Protein Kinase Catalytic Subunit. Am J Pathol (2016) 0.76

Musashi mediates translational repression of the Drosophila hypoxia inducible factor. Nucleic Acids Res (2016) 0.76

The RNA-Binding Protein Musashi1: A Major Player in Intestinal Epithelium Renewal and Colon Cancer Development. Curr Colorectal Cancer Rep (2012) 0.76

Suppression of intestinal tumorigenesis in Apc mutant mice by Musashi-1 deletion. J Cell Sci (2017) 0.75

Neural stem and progenitor cell fate transition requires regulation of Musashi1 function. BMC Dev Biol (2015) 0.75

msBiodat analysis tool, big data analysis for high-throughput experiments. BioData Min (2016) 0.75

Articles cited by this

Primer3 on the WWW for general users and for biologist programmers. Methods Mol Biol (2000) 128.08

Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol (2004) 101.91

DAVID: Database for Annotation, Visualization, and Integrated Discovery. Genome Biol (2003) 84.79

Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci U S A (2003) 59.17

Empirical statistical model to estimate the accuracy of peptide identifications made by MS/MS and database search. Anal Chem (2002) 35.30

A statistical model for identifying proteins by tandem mass spectrometry. Anal Chem (2003) 29.58

Ensembl 2008. Nucleic Acids Res (2007) 20.67

RNA regulons: coordination of post-transcriptional events. Nat Rev Genet (2007) 10.12

Absolute protein expression profiling estimates the relative contributions of transcriptional and translational regulation. Nat Biotechnol (2006) 9.95

Myc signaling via the ARF tumor suppressor regulates p53-dependent apoptosis and immortalization. Genes Dev (1998) 9.03

ARF promotes MDM2 degradation and stabilizes p53: ARF-INK4a locus deletion impairs both the Rb and p53 tumor suppression pathways. Cell (1998) 8.99

Noxa, a BH3-only member of the Bcl-2 family and candidate mediator of p53-induced apoptosis. Science (2000) 8.74

A comparison of background correction methods for two-colour microarrays. Bioinformatics (2007) 8.59

The Ink4a tumor suppressor gene product, p19Arf, interacts with MDM2 and neutralizes MDM2's inhibition of p53. Cell (1998) 8.33

HES and HERP families: multiple effectors of the Notch signaling pathway. J Cell Physiol (2003) 7.32

Functional and physical interactions of the ARF tumor suppressor with p53 and Mdm2. Proc Natl Acad Sci U S A (1998) 5.74

Identifying mRNA subsets in messenger ribonucleoprotein complexes by using cDNA arrays. Proc Natl Acad Sci U S A (2000) 4.99

p14ARF links the tumour suppressors RB and p53. Nature (1998) 4.78

Eukaryotic mRNPs may represent posttranscriptional operons. Mol Cell (2002) 4.39

Identification of a putative intestinal stem cell and early lineage marker; musashi-1. Differentiation (2003) 3.41

NUMB controls p53 tumour suppressor activity. Nature (2008) 2.91

The neural RNA-binding protein Musashi1 translationally regulates mammalian numb gene expression by interacting with its mRNA. Mol Cell Biol (2001) 2.87

RNA-binding protein Musashi family: roles for CNS stem cells and a subpopulation of ependymal cells revealed by targeted disruption and antisense ablation. Proc Natl Acad Sci U S A (2002) 2.79

Mouse-Musashi-1, a neural RNA-binding protein highly enriched in the mammalian CNS stem cell. Dev Biol (1996) 2.68

Integral role of Noxa in p53-mediated apoptotic response. Genes Dev (2003) 2.50

Musashi1: an evolutionally conserved marker for CNS progenitor cells including neural stem cells. Dev Neurosci (2000) 2.36

Post-transcriptional gene regulation: from genome-wide studies to principles. Cell Mol Life Sci (2008) 2.18

Expression of neural RNA-binding proteins in the postnatal CNS: implications of their roles in neuronal and glial cell development. J Neurosci (1997) 1.79

The RNA-binding protein Musashi-1 regulates neural development through the translational repression of p21WAF-1. Mol Cell Neurosci (2005) 1.72

Knockdown of RNA binding protein musashi-1 leads to tumor regression in vivo. Gastroenterology (2008) 1.68

Mammary tumor induction in transgenic mice expressing an RNA-binding protein. Cancer Res (2004) 1.62

Calculating absolute and relative protein abundance from mass spectrometry-based protein expression data. Nat Protoc (2008) 1.62

Post-transcriptional operons and regulons co-ordinating gene expression. Chromosome Res (2005) 1.57

Neural RNA-binding protein Musashi1 inhibits translation initiation by competing with eIF4G for PABP. J Cell Biol (2008) 1.56

Musashi regulates the temporal order of mRNA translation during Xenopus oocyte maturation. EMBO J (2006) 1.49

Musashi1 modulates mammary progenitor cell expansion through proliferin-mediated activation of the Wnt and Notch pathways. Mol Cell Biol (2008) 1.47

Post-transcription meets post-genomic: the saga of RNA binding proteins in a new era. RNA Biol (2006) 1.18

Systems perspectives on mRNA processing. Cell Res (2007) 1.17

The RNA-binding protein Musashi is required intrinsically to maintain stem cell identity. Proc Natl Acad Sci U S A (2006) 1.16

Biotinylated tags for recovery and characterization of ribonucleoprotein complexes. Biotechniques (2004) 1.09

Musashi1 modulates cell proliferation genes in the medulloblastoma cell line Daoy. BMC Cancer (2008) 1.04

RNA-binding proteins to assess gene expression states of co-cultivated cells in response to tumor cells. Mol Cancer (2004) 1.04

Isolation and characterization of human mammary stem cells. Cell Prolif (2005) 1.03

Ubiquitin hubs in oncogenic networks. Mol Cancer Res (2006) 0.89

Discovering well-ordered folding patterns in nucleotide sequences. Bioinformatics (2003) 0.88

Expression and functional analysis of musashi-like genes in planarian CNS regeneration. Mech Dev (2008) 0.86

Musashi1 RNA-binding protein regulates oligodendrocyte lineage cell differentiation and survival. Glia (2008) 0.85

Over-represented sequences located on 3' UTRs are potentially involved in regulatory functions. RNA Biol (2008) 0.81

Articles by these authors

Absolute protein expression profiling estimates the relative contributions of transcriptional and translational regulation. Nat Biotechnol (2006) 9.95

The SUPERFAMILY database in 2004: additions and improvements. Nucleic Acids Res (2004) 6.72

A compendium of RNA-binding motifs for decoding gene regulation. Nature (2013) 4.91

Global signatures of protein and mRNA expression levels. Mol Biosyst (2009) 4.43

The SUPERFAMILY database in 2007: families and functions. Nucleic Acids Res (2006) 4.27

Evolution of the protein repertoire. Science (2003) 4.24

Aberrant expression of oncogenic and tumor-suppressive microRNAs in cervical cancer is required for cancer cell growth. PLoS One (2008) 4.24

Evidence that HIV-1 encodes an siRNA and a suppressor of RNA silencing. Immunity (2005) 3.70

Sequence signatures and mRNA concentration can explain two-thirds of protein abundance variation in a human cell line. Mol Syst Biol (2010) 3.56

miR-33a/b contribute to the regulation of fatty acid metabolism and insulin signaling. Proc Natl Acad Sci U S A (2011) 3.35

SUPERFAMILY--sophisticated comparative genomics, data mining, visualization and phylogeny. Nucleic Acids Res (2008) 3.07

MicroRNA-16 and microRNA-424 regulate cell-autonomous angiogenic functions in endothelial cells via targeting vascular endothelial growth factor receptor-2 and fibroblast growth factor receptor-1. Arterioscler Thromb Vasc Biol (2011) 2.31

HIV-1 encoded candidate micro-RNAs and their cellular targets. Retrovirology (2004) 2.23

In vitro assembly of cubic RNA-based scaffolds designed in silico. Nat Nanotechnol (2010) 1.96

RNAJunction: a database of RNA junctions and kissing loops for three-dimensional structural analysis and nanodesign. Nucleic Acids Res (2007) 1.83

RNA2D3D: a program for generating, viewing, and comparing 3-dimensional models of RNA. J Biomol Struct Dyn (2008) 1.72

Protein abundances are more conserved than mRNA abundances across diverse taxa. Proteomics (2010) 1.71

Pyrosequencing of small non-coding RNAs in HIV-1 infected cells: evidence for the processing of a viral-cellular double-stranded RNA hybrid. Nucleic Acids Res (2009) 1.69

The APEX Quantitative Proteomics Tool: generating protein quantitation estimates from LC-MS/MS proteomics results. BMC Bioinformatics (2008) 1.54

Self-assembling RNA nanorings based on RNAI/II inverse kissing complexes. Nano Lett (2011) 1.49

Site identification in high-throughput RNA-protein interaction data. Bioinformatics (2012) 1.43

Glucosinolate biosynthesis: demonstration and characterization of the condensing enzyme of the chain elongation cycle in Eruca sativa. Phytochemistry (2004) 1.41

Integrating shotgun proteomics and mRNA expression data to improve protein identification. Bioinformatics (2009) 1.36

The 3' proximal translational enhancer of Turnip crinkle virus binds to 60S ribosomal subunits. RNA (2008) 1.29

Integrated mapping, chromosomal sequencing and sequence analysis of Cryptosporidium parvum. Genome Res (2003) 1.29

Computational design of an RNA hexagonal nanoring and an RNA nanotube. Nano Lett (2007) 1.27

Design and self-assembly of siRNA-functionalized RNA nanoparticles for use in automated nanomedicine. Nat Protoc (2011) 1.27

Kaposi's sarcoma-associated herpesvirus ORF57 promotes escape of viral and human interleukin-6 from microRNA-mediated suppression. J Virol (2011) 1.25

Genomic analyses of the RNA-binding protein Hu antigen R (HuR) identify a complex network of target genes and novel characteristics of its binding sites. J Biol Chem (2011) 1.24

Solution structure of the cap-independent translational enhancer and ribosome-binding element in the 3' UTR of turnip crinkle virus. Proc Natl Acad Sci U S A (2010) 1.23

Before It Gets Started: Regulating Translation at the 5' UTR. Comp Funct Genomics (2012) 1.22

Structural domains within the 3' untranslated region of Turnip crinkle virus. J Virol (2008) 1.21

The role of cytokine mRNA stability in the pathogenesis of autoimmune disease. Autoimmun Rev (2005) 1.21

RNA secondary structure prediction from sequence alignments using a network of k-nearest neighbor classifiers. RNA (2006) 1.19

MSblender: A probabilistic approach for integrating peptide identifications from multiple database search engines. J Proteome Res (2011) 1.19

Post-transcription meets post-genomic: the saga of RNA binding proteins in a new era. RNA Biol (2006) 1.18

The (in)dependence of alternative splicing and gene duplication. PLoS Comput Biol (2007) 1.17

A boost for the emerging field of RNA nanotechnology. ACS Nano (2011) 1.17

A method for helical RNA global structure determination in solution using small-angle x-ray scattering and NMR measurements. J Mol Biol (2009) 1.16

CorreLogo: an online server for 3D sequence logos of RNA and DNA alignments. Nucleic Acids Res (2006) 1.15

Computational strategies for the automated design of RNA nanoscale structures from building blocks using NanoTiler. J Mol Graph Model (2008) 1.14

Two-tiered approach identifies a network of cancer and liver disease-related genes regulated by miR-122. J Biol Chem (2011) 1.11

A pseudoknot in a preactive form of a viral RNA is part of a structural switch activating minus-strand synthesis. J Virol (2006) 1.11

RNA-binding protein HuR interacts with thrombomodulin 5'untranslated region and represses internal ribosome entry site-mediated translation under IL-1 beta treatment. Mol Biol Cell (2008) 1.07

Stability of a long noncoding viral RNA depends on a 9-nt core element at the RNA 5' end to interact with viral ORF57 and cellular PABPC1. Int J Biol Sci (2011) 1.06

Next-generation analysis of gene expression regulation--comparing the roles of synthesis and degradation. Mol Biosyst (2015) 1.06

Musashi1 modulates cell proliferation genes in the medulloblastoma cell line Daoy. BMC Cancer (2008) 1.04

The prediction of the wild-type telomerase RNA pseudoknot structure and the pivotal role of the bulge in its formation. J Mol Graph Model (2006) 1.04

Multifunctional RNA nanoparticles. Nano Lett (2014) 1.03

Correlating SHAPE signatures with three-dimensional RNA structures. RNA (2011) 1.03

The oncogenic RNA-binding protein Musashi1 is regulated by HuR via mRNA translation and stability in glioblastoma cells. Mol Cancer Res (2012) 1.02

Multistrand RNA secondary structure prediction and nanostructure design including pseudoknots. ACS Nano (2011) 1.02

Identification of cis-acting elements in the 3'-untranslated region of the dengue virus type 2 RNA that modulate translation and replication. J Biol Chem (2011) 1.01

A base-specific recognition signal in the 5' consensus sequence of rotavirus plus-strand RNAs promotes replication of the double-stranded RNA genome segments. RNA (2005) 1.00

The RNA-binding protein Musashi1 affects medulloblastoma growth via a network of cancer-related genes and is an indicator of poor prognosis. Am J Pathol (2012) 0.98

Co-transcriptional assembly of chemically modified RNA nanoparticles functionalized with siRNAs. Nano Lett (2012) 0.98

The oncogenic RNA-binding protein Musashi1 is regulated by tumor suppressor miRNAs. RNA Biol (2011) 0.98

Mapping and characterization of the minimal internal ribosome entry segment in the human c-myc mRNA 5' untranslated region. Oncogene (2004) 0.96

Mining gene functional networks to improve mass-spectrometry-based protein identification. Bioinformatics (2009) 0.96

Structural differentiation of the HIV-1 polyA signals. J Biomol Struct Dyn (2006) 0.96

A ribosome-binding, 3' translational enhancer has a T-shaped structure and engages in a long-distance RNA-RNA interaction. J Virol (2012) 0.95

Dynamic behavior of the telomerase RNA hairpin structure and its relationship to dyskeratosis congenita. J Mol Biol (2005) 0.95

Structural polymorphism of the HIV-1 leader region explored by computational methods. Nucleic Acids Res (2005) 0.94

The extent of sequence complementarity correlates with the potency of cellular miRNA-mediated restriction of HIV-1. Nucleic Acids Res (2012) 0.94

Use of RNA structure flexibility data in nanostructure modeling. Methods (2010) 0.94

The role of a metastable RNA secondary structure in hepatitis delta virus genotype III RNA editing. RNA (2006) 0.94

Food restriction increases glutamate receptor-mediated burst firing of dopamine neurons. J Neurosci (2013) 0.92

Translation regulation gets its 'omics' moment. Wiley Interdiscip Rev RNA (2013) 0.92

The A-rich RNA sequences of HIV-1 pol are important for the synthesis of viral cDNA. Nucleic Acids Res (2008) 0.92

A comprehensive in silico expression analysis of RNA binding proteins in normal and tumor tissue: Identification of potential players in tumor formation. RNA Biol (2009) 0.91

In Silico, In Vitro, and In Vivo Studies Indicate the Potential Use of Bolaamphiphiles for Therapeutic siRNAs Delivery. Mol Ther Nucleic Acids (2013) 0.91

RADAR: a web server for RNA data analysis and research. Nucleic Acids Res (2007) 0.91

Musashi1: an RBP with versatile functions in normal and cancer stem cells. Front Biosci (Landmark Ed) (2012) 0.90

CyloFold: secondary structure prediction including pseudoknots. Nucleic Acids Res (2010) 0.90

A comparison between elastic network interpolation and MD simulation of 16S ribosomal RNA. J Biomol Struct Dyn (2003) 0.90

The origin of chromosome imbalances in neuroblastoma. Cancer Genet Cytogenet (2007) 0.89

Buffering by gene duplicates: an analysis of molecular correlates and evolutionary conservation. BMC Genomics (2008) 0.89

Molecular modeling and dynamics studies of HIV-1 kissing loop structures. J Biomol Struct Dyn (2002) 0.89

Role of 3'UTRs in the translation of mRNAs regulated by oncogenic eIF4E--a computational inference. PLoS One (2009) 0.88

Structural complexity of Dengue virus untranslated regions: cis-acting RNA motifs and pseudoknot interactions modulating functionality of the viral genome. Nucleic Acids Res (2013) 0.88

Triggering of RNA interference with RNA-RNA, RNA-DNA, and DNA-RNA nanoparticles. ACS Nano (2014) 0.88